Vergoeding 2019-2023 voor ATC-subgroep L04AA : Selectieve immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| L04AA06 Mycofenolzuur (Cellcept ®) | 11.741.300 | 11.762.200 | 9.562.600 | 9.749.100 | 10.953.900 |
| L04AA10 Sirolimus | 5.694 | 1.663 | . | . | . |
| L04AA13 Leflunomide | 182.810 | 39.046 | 11.237 | 1.561 | . |
| L04AA18 Everolimus | 287.120 | 219.320 | 86.153 | 14.121 | . |
| L04AA27 Fingolimod | 4.334.900 | 3.667.000 | 1.165.300 | 763.190 | 1.531 |
| L04AA40 Cladribine (Mavenclad ®) | 4.653.000 | 3.939.500 | 5.276.500 | 10.297.100 | 15.392.500 |
| Totaal | 21.204.824 | 19.628.729 | 16.101.790 | 20.825.072 | 26.347.931 |